menu
    • menu

    Company profile for IASO Bio

    NEW Drugs in Dev: 12
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IASO Bio is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and autoimmune diseases. Leveraging its proprietary fully human antibody discovery platform (IMARS), high-throughput CAR-T drug priority platform, and proprietary manufacturing processes, IASO Bio is developing a rich clinical-stage pipeline of multiple autologous and allogeneic CAR-T and biologi...
    IASO Bio is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and autoimmune diseases. Leveraging its proprietary fully human antibody discovery platform (IMARS), high-throughput CAR-T drug priority platform, and proprietary manufacturing processes, IASO Bio is developing a rich clinical-stage pipeline of multiple autologous and allogeneic CAR-T and biologics product candidates. Currently, the company is developing a diversified portfolio of over 10 novel pipeline products. ASO’s leading asset, CT103A, an innovative anti-BCMA CAR T- cell therapy

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IASO BioChina Flag
    Country
    Country
    China
    Address
    Address
    floor 8-10, building D, zhongdanyuan, 3-1 xinjinhu road, jiangbei new distric...
    Telephone
    Telephone
    025-58287610
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.iasobio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IASO Bio Forms Global Partnership With Instituto Butantan
    IASO Bio Forms Global Partnership With Instituto Butantan

    10 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iaso-bio-establishes-international-partnership-with-instituto-butantan-to-develop-innovative-therapy-for-hematological-cancer-302739305.html

    PR NEWSWIRE
    10 Apr 2026
    Share Share
    IASO Bio Cleared By Japan's PMDA For CAR-T Therapy Trial
    IASO Bio Cleared By Japan's PMDA For CAR-T Therapy Trial

    24 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iaso-bio-has-received-clearance-from-japans-pmda-to-initiate-clinical-trial-for-car-t-therapy-equecabtagene-autoleucel-in-second--or-third-line-multiple-myeloma-302723126.html

    PR NEWSWIRE
    24 Mar 2026
    Share Share
    Iaso Therapeutics Showcases mQ? Vaccine at 2026 World Congress
    Iaso Therapeutics Showcases mQ? Vaccine at 2026 World Congress

    18 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iaso-therapeutics-to-showcase-novel-mq-vaccine-platform-at-2026-world-vaccine-congress-302691204.html

    PR NEWSWIRE
    18 Feb 2026
    Share Share
    Hong Kong Approves IASO Bio's Fucaso for R/R Myeloma
    Hong Kong Approves IASO Bio's Fucaso for R/R Myeloma

    27 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iaso-bio-announces-bla-approval-of-fucaso-equecabtagene-autoleucel-by-the-hong-kong-department-of-health-for-the-treatment-of-relapsed-or-refractory-multiple-myeloma-302627345.html

    PR NEWSWIRE
    27 Nov 2025
    Share Share
    IASO Bio Partners With GC Cell For CAR-T Therapy In Korea
    IASO Bio Partners With GC Cell For CAR-T Therapy In Korea

    29 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iaso-bio-partners-with-koreas-gc-cell-to-bring-car-t-therapy-to-korea-302598178.html

    PR NEWSWIRE
    29 Oct 2025
    Share Share
    IASO Bio’s Anti-GPRC5D CAR-T RD118 Shows Promise in R/R Myeloma
    IASO Bio’s Anti-GPRC5D CAR-T RD118 Shows Promise in R/R Myeloma

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/blood-publishes-promising-results-of-iaso-bios-anti-gprc5d-car-t-rd118-in-relapsedrefractory-multiple-myeloma-302591431.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search